Science and technology innovation drives future economic growth. Today, the medical technology industry supported by emerging technologies such as artificial intelligence, big data, and cloud computing is on the rise. The combination of traditional medical and intelligent technologies has prompted the entire industry to enter an upgrade and subversive adjustment. A new business model will improve the efficiency of the industry and bring unlimited business opportunities.
On November 14, 2017, the “OFweek2017 (4th) China Hi-Tech Industry Investment and Financing Forum and Project Roadshow†hosted by OFweek China Hi-Tech Industry Portal and the High-tech Association's OFweek Investment and Financing Network was held in Shenzhen. The conference was one of the sub-forums of the China High-Tech Industry Conference. The all-day conference was divided into medical special sessions (AM) and high-tech special sessions (afternoon). A total of 19 entrepreneurial project roadshows were held, including 9 medical special projects. The event aims to promote technological innovation and talent development, help technology companies and investment institutions to better understand the trend of industry development and the value of the company itself, and build a platform for investment and cooperation.
Human society has developed rapidly with the advancement of science and technology. Big data analysis has provided strong support for medical diagnosis. Artificial intelligence has improved the efficiency of dealing with various complex diseases. Through cloud computing, it can better collect medical information and cognitive world. Bringing more precise surgery, 3D printing is a high-end technology that helps the medical industry to achieve medical vision in the past. More and more companies are beginning to devote themselves to the field of medical technology, using technology innovation to break the shackles of traditional industry development, so who will become the next dark horse? More and more intelligent technology products have emerged one after another, how will the investment community determine, and where is the new market for the medical industry? In order to help the industry to clarify these technology companies and industry context, OFweek China's high-tech industry portal to set up investment and financing exchange platform, invite top authoritative experts and industry big coffee to share the latest technological achievements and unique insights into the industry, open the final of the capital market and technology projects one kilometer.
The guests present at the conference included Mr. Li Xiaoyang, CEO of OFweek and Executive Vice President of the High-Tech Association. Mr. Guan Tao, Partner of Investment Management, Mr. Li Jin, Managing Partner of Aussie Capital, Mr. Zhang Huali, General Manager of Handan Medical, and Ji Changtao, Director of Shared Investment of Huada Mr. In addition, it also invited from Dachen Venture Capital, Oriental Haifu, Shenzhen Venture Capital, Songhe Capital, Qifu Capital, Chuangdong, Tongchuang Weiye, Lihe Qingyuan, China Venture Capital Co., Ltd., Gaoxintou, Aurora Bore More than 100 domestic well-known investment institutions investors came to the scene.
Inviting Ji Daheng, the investment director of Huada, to be the moderator of this conference (medical special session), with the theme of “intelligence-aware innovation driveâ€. At the meeting, the organizer OFweek CEO and Executive Vice President of the High-Tech Association, Mr. Li Xiaoyang, said that science and technology has always been the key driving force for human progress. Today, the new generation of information technology represented by artificial intelligence, big data and cloud computing is giving human society. Have a profound impact. At the turning point of the new economy, companies should think about how to invest in the layout in advance and how to occupy the future development highlands. This conference will focus on artificial intelligence and medical technology, and will extend to areas such as intelligent driverless, intelligent hardware, and robotics. As the organizer of this event--OFweek China High-tech Industry Portal has rich industry resources. Our investment and financing platform is committed to providing investors with multi-project services such as project management and M&A consulting to help enterprises achieve cross-border win-win and achieve Industry chain integration and value enhancement. For entrepreneurs, we provide services such as counseling financing and entrepreneurial accelerators, and promote the rapid growth of the technology industry with a model of resource sharing. We investigated and analyzed a large number of failed investment cases, identified some major factors for project failure, and made resource adjustments and assistance in the process of project development through sharing with our resources, which can help both investment and financing to control project operational risks. Improve the success rate of investment projects and greatly increase the value of investment.
Guest Speech 1: Opportunities and Challenges in the Biomedical Industry
Since 2015, the entire biomedical system has become hot. China has put forward a strategic policy of building a well-off society in an all-round way and implementing a healthy China. The United States has launched a precision medical plan. Coupled with the promotion of the media and information communication industry, human attention to health has risen to a new level. Zhang Huali, general manager of Handan Medical, said that capital has been investing in the biomedical field for many years and gradually promoted the industrialization effect. People have begun to use the essential laws of life to carry out adjustments to the laws of life in order to improve the health of human beings.
From the industrial point of view, biomedical has the conditions of time, location and people. China has a huge market and the continuous growth of professional talents promotes the rapid development of biomedical. At present, the main domestic market is divided by foreign companies, while domestic products are mainly low and medium-end. However, with the gradual maturity of technology, more and more biomedical companies have emerged in China, and the strategy of China's medical reform and globalization has given birth to huge opportunities in the domestic medical market.
From the perspective of capital, some medical projects that occur overseas will eventually occur in China, and China is upgrading from production to technology and innovative industries. Zhang Huali pointed out that capital will be popular in emerging industries, and biomedical is a high barrier, an evergreen industry, and the arrival of the equity era, a wave of advanced technology and engineering technology brings new opportunities.
Guest Speech 2: Venture Capital Opportunities in the Medical Segment
With the increasing willingness and ability of government and nationals to pay for medical services, China's total medical expenditure continues to grow at a high rate, especially in 2008-2012, with a compound growth rate of 20%, far surpassing that of other big countries. The industry analyzes China in 2019. Total medical expenditure will increase to 737.90 billion yuan. Although the total amount of medical expenditure in China is huge, the amount of medical expenditure per capita does not match the total amount. According to Guan Tao, a partner who shares investment management, China’s medical care reflects the obvious scarcity of per capita medical resources, which will help promote new The development of a generation of medical technology.
With the development of molecular biology in recent decades, clinical medicine calls for new medical concepts, and Obama has proposed the "precise medical" program, bringing us into the era of precision medicine. Precision medicine requires the establishment of new medical practice models and diagnostic systems to give the right people the right treatment at the right time. These innovative technologies are expected to subvert the existing medical model.
According to Guan Tao, the precise and accurate medical industry is mainly distributed in the frontier innovative devices, diagnostic testing equipment and reagents, drug research and development, medical health services and mobile medical . At present, the investment strategies in different start-up medical fields are different brands, such as instruments, medicines, biotechnology, medical services and mobile medicine. The common investment stage is to set up Angel, A, B and Pre-IPO. The main sources of funds are debt financing, equity financing and the founding team members' own savings. Guan Tao pointed out that at this stage of China, it is necessary to select angel funds to select a partner's standard and make rational resource allocation planning. It is not appropriate to give up most of the company's shares too early. Medical entrepreneurs need investors who make too fast. Be vigilant.
Project roadshow
The medical industry reform is in the midst of a turbulent phase. The National Health and Family Planning Commission and other departments have successively issued a number of policies and regulations. The medical industry has entered the fast lane of development under the new policy. The upgrading effect of new technologies such as artificial intelligence and big data on the medical industry is unquestionable. The roadshow's projects include Internet telemedicine , medical cloud platform, big data management analysis, artificial intelligence services, rehabilitation robots and other selected projects, including AI and cloud services for medical imaging analysis and clinical application solutions, High-intensity focused ultrasound tumor treatment system, professional tumor data center and radiotherapy cloud platform, the world's first half-face facial syndrome (CFM) prenatal testing kit industrialization, non-invasive cerebral blood oxygen monitor, early use of liquid biopsy Tumor screening, telemedicine big data health management cloud platform, hand movement function rehabilitation robot, new biological oral preparation - sugar needle capsule.
1. RayPlus intelligent medical imaging (assisting doctors to make efficient, accurate and individualized medical decisions)
2, high-intensity self-focusing ultrasound tumor treatment system - HKSFU (HKSFU has personalized treatment adaptability, resulting in a wider range of indications, higher product clinical efficiency)
3, professional tumor data center and radiotherapy cloud platform
4. The world's first half-face face short syndrome (CFM) prenatal testing kit (constructed CFM diagnosis and treatment integrated ecological community with early screening as the starting point and patient flow management as the path)
5, non-invasive cerebral blood oxygen monitor (to comprehensive monitoring of blood oxygen information, to protect brain cognitive function)
6, using liquid biopsy for early tumor screening (only 10ml of blood, you can detect whether the body has developed early cancer)
7, telemedicine big data health management cloud platform (to further apply large health data to personal insurance assessment, personal authentication)
8, hand movement function rehabilitation robot (based on virtual implementation technology, using brain-computer interface and technology, so that stroke patients with hemiplegia regain "life")
9. New biological oral preparations - Sugar Needle Capsule (can transport any biological medicine, absorbs faster, better and lower cost than large-scale production.)
The roadshow projects at this conference are all selected by the organizers to select the best entrepreneurial cases, which have great reference significance for the development of medical innovation in the industry. Investors from all walks of life have been struggling to find potential projects, and entrepreneurs are hoping to meet the favor of capital as soon as possible. Through this investment and financing forum and project roadshow, investors will have a deep understanding of the status quo and trends of the technology industry, and at the same time let entrepreneurs further recognize the true ideas of investors, promote the docking of research projects and capital markets, and promote the entire high The science and technology industry has entered a high-speed development, allowing technology to rapidly transform into economic value growth.
As the organizer of this event, OFweek China's high-tech industry portal has held several industry seminars and investment and financing conferences in the past few years, involving artificial intelligence, internet of things, medical technology, electronic engineering, photovoltaic, laser, led lighting. , lithium battery, new energy vehicles, robots, industrial control and other scientific and technological fields, and caused widespread response in various industries. For more exciting content of this event or to learn more about business opportunities, please pay attention to the follow-up reports and related topics of OFweek China's high-tech industry portal.
Single Packed Mottled Waxy Corn
Waxy corn comes in a variety of colours. Some people wonder if waxy corn is a genetically modified product. In fact, it is not. Waxy corn originated in China. It is caused by a genetic mutation. Artificial selection gradually led to the emergence of a type of tannin.
Waxy corn, also known as waxy corn, is sticky corn. The grain has coarse, waxy endosperm, similar to shiny, glassy (clear) grains such as hard and dented corn. Its chemical and physical characteristics are controlled by a recessive gene (wx), which is located on chromosome 9. 100% of the starch in the endosperm is straight-chain starch.
Coloured glutinous corn is generally white, yellow, red, purple and black, with white, yellow and purple corn being the basic colours. Purple and white hybrids naturally become purple if the purple gene "beats" the white gene and vice versa, so if the two tie we see white and purple corn. Purple can turn into red and black corn, or as we often say, "red is purple and black is purple". Of these colourful corn, the most common yellow waxy corn is the most nutritious as it is rich in carotenoids...
Currently, the only genetically modified foods sold on the Chinese market are soybean oil and papaya. Waxy maize is a hybrid variety and is not associated with genetic modification. Therefore, it can be concluded that glutinous maize is a hybrid variety and has nothing to do with genetic modification.
Genetic modification is a type of "genetic engineering" in modern science and technology, which makes use of modern molecular biology techniques. Hybridisation is the mating of individuals of different genotypes to produce offspring that are different from the original "pure" breed. In a sense, it belongs to the natural exchange of genes that can occur in nature.
Colorful Waxy Corn,Colorful Mottled Waxy Corn,Single Packed Mottled Waxy Corn,Single Packed Colorful Waxy Corn
Jilin Province Argricultural Sister-in-law Food Co., Ltd. , https://www.nscorn.com